AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
THE USE OF 4-AMINOBIPHENYL HEMOGLOBIN ADDUCTS AND AROMATIC DNA-ADDUCTS IN LYMPHOCYTES OF SMOKERS AS BIOMARKERS OF EXPOSURE
Authors: DALLINGA JW PACHEN DMFA WIJNHOVEN SWP BREEDIJK A VANTVEER L WIGBOUT G VANZANDWIJK N MAAS LM VANAGEN E KLEINJANS JCS VANSCHOOTEN FJ
Citation: Jw. Dallinga et al., THE USE OF 4-AMINOBIPHENYL HEMOGLOBIN ADDUCTS AND AROMATIC DNA-ADDUCTS IN LYMPHOCYTES OF SMOKERS AS BIOMARKERS OF EXPOSURE, Cancer epidemiology, biomarkers & prevention, 7(7), 1998, pp. 571-577
COMMENTS ON ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, VAN-ZANDWIJK ET-AL., EUR J CANCER 1997, 33, 1759-1766 - RESPONSE FROM VANZANDWIJK,N
Authors: VANZANDWIJK N
Citation: N. Vanzandwijk, COMMENTS ON ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, VAN-ZANDWIJK ET-AL., EUR J CANCER 1997, 33, 1759-1766 - RESPONSE FROM VANZANDWIJK,N, European journal of cancer, 34(10), 1998, pp. 1638-1638
THE ROLE OF PROGNOSTIC FACTORS AND ONCOGENES IN THE DETECTION AND MANAGEMENT OF NON-SMALL-CELL LUNG-CANCER
Authors: VANZANDWIJK N VANTVEER LJ
Citation: N. Vanzandwijk et Lj. Vantveer, THE ROLE OF PROGNOSTIC FACTORS AND ONCOGENES IN THE DETECTION AND MANAGEMENT OF NON-SMALL-CELL LUNG-CANCER, Oncology, 12(1), 1998, pp. 55-59
RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: GIACCONE G SPLINTER TAW DEBRUYNE C KHO GS LIANES P VANZANDWIJK N PENNUCCI MC SCAGLIOTTI G VANMEERBEECK J VANHOESEL Q CURRAN D SAHMOUD T POSTMUS PE
Citation: G. Giaccone et al., RANDOMIZED STUDY OF PACLITAXEL-CISPLATIN VERSUS CISPLATIN-TENIPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2133-2141
DIFFERENCES IN AROMATIC-DNA ADDUCT LEVELS BETWEEN ALVEOLAR MACROPHAGES AND SUBPOPULATIONS OF WHITE BLOOD-CELLS FROM SMOKERS
Authors: GODSCHALK RWL MAAS LM VANZANDWIJK N VANTVEER LJ BREEDIJK A BORM PJA VERHAERT J KLEINJANS JCS VANSCHOOTEN FJ
Citation: Rwl. Godschalk et al., DIFFERENCES IN AROMATIC-DNA ADDUCT LEVELS BETWEEN ALVEOLAR MACROPHAGES AND SUBPOPULATIONS OF WHITE BLOOD-CELLS FROM SMOKERS, Carcinogenesis, 19(5), 1998, pp. 819-825
OXIDATIVE STRESS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: REPINE JE LANKHORST I DEBACKER W DEKHUIJZEN R DEMEDTS M VANHERWAARDEN C VANKLAVEREN R LAMMERS JW LARSSON S LUNDBACK B PETRUZELLI S POSTMA D RIISE G VERMEIRE P WOUTERS E YERNAULT JC VANZANDWIJK N
Citation: Je. Repine et al., OXIDATIVE STRESS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, American journal of respiratory and critical care medicine, 156(2), 1997, pp. 341-357
ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: SAHMOUD T POSTMUS PE VANPOTTELSBERGHE C MATTSON K TAMMILEHTO L SPLINTER TAW PLANTING AST SUTEDJA T VANPAWEL J VANZANDWIJK N BAAS P ROOZENDAAL KJ SCHRIJVER M KIRKPATRICK A VANGLABBEKE M ARDIZZONI A GIACCONE G
Citation: T. Sahmoud et al., ETOPOSIDE IN MALIGNANT PLEURAL MESOTHELIOMA - 2 PHASE-II TRIALS OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(13), 1997, pp. 2211-2215
ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: VANZANDWIJK N GROEN HJM POSTMUS PE BURGHOUTS JTW TENVELDE GPM ARDIZZONI A SMITH IE BAAS P SAHMOUD T KIRKPATRICK A DALESIO O GIACCONE G
Citation: N. Vanzandwijk et al., ROLE OF RECOMBINANT INTERFERON-GAMMA MAINTENANCE IN RESPONDING PATIENTS WITH SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, European journal of cancer, 33(11), 1997, pp. 1759-1766
MUTATIONAL ACTIVATION OF THE K-RAS ONCOGENE AND THE EFFECT OF CHEMOTHERAPY IN ADVANCED ADENOCARCINOMA OF THE LUNG - A PROSPECTIVE-STUDY
Authors: RODENHUIS S BOERRIGTER L TOP B SLEBOS RJC MOOI WJ VANTVEER L VANZANDWIJK N
Citation: S. Rodenhuis et al., MUTATIONAL ACTIVATION OF THE K-RAS ONCOGENE AND THE EFFECT OF CHEMOTHERAPY IN ADVANCED ADENOCARCINOMA OF THE LUNG - A PROSPECTIVE-STUDY, Journal of clinical oncology, 15(1), 1997, pp. 285-291
PHARMACOKINETICS OF PACLITAXEL AND CARBOPLAT DOSE-ESCALATING AND DOSE-SEQUENCING STUDY IN WITH NON-SMALL-CELL LONG CANCER
Authors: HUIZING MT GIACCONE G VANWARMERDAM LJC ROSING H BAKKER PJM VERMORKEN JB POSTMUS PE VANZANDWIJK N KOOLEN MGJ HUININK WWTB VANDERVIJGH WJF BIERHORST FJ LAI A DALESIO O PINEDO HM VEENHOF CHN BEIJNEN JH
Citation: Mt. Huizing et al., PHARMACOKINETICS OF PACLITAXEL AND CARBOPLAT DOSE-ESCALATING AND DOSE-SEQUENCING STUDY IN WITH NON-SMALL-CELL LONG CANCER, Journal of clinical oncology, 15(1), 1997, pp. 317-329
APPLICATOR FOR LIGHT DELIVERY AND IN-SITU LIGHT DOSIMETRY DURING ENDOBRONCHIAL PHOTODYNAMIC THERAPY - FIRST MEASUREMENTS IN HUMANS
Authors: MURRER LHP MARIJNISSEN JPA BAAS P VANZANDWIJK N STAR WM
Citation: Lhp. Murrer et al., APPLICATOR FOR LIGHT DELIVERY AND IN-SITU LIGHT DOSIMETRY DURING ENDOBRONCHIAL PHOTODYNAMIC THERAPY - FIRST MEASUREMENTS IN HUMANS, Lasers in medical science, 12(3), 1997, pp. 253-259
CLINICAL-PHARMACOLOGY OF CARBOPLATIN ADMINISTERED IN COMBINATION WITHPACLITAXEL
Authors: VANWARMERDAM LJC HUIZING MT GIACCONE G POSTMUS PE HUININK WWT VANZANDWIJK N KOOLEN MGJ HELMERHORST TJM VANDERVIJGH WJF VEENHOF CHN BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., CLINICAL-PHARMACOLOGY OF CARBOPLATIN ADMINISTERED IN COMBINATION WITHPACLITAXEL, Seminars in oncology, 24(1), 1997, pp. 97-104
P-32 POSTLABELING OF AROMATIC DNA-ADDUCTS IN WHITE BLOOD-CELLS AND ALVEOLAR MACROPHAGES OF SMOKERS - SATURATION AT HIGH EXPOSURES
Authors: VANSCHOOTEN FJ GODSCHALK RWL BREEDIJK A MAAS LM KRIEK E SAKAI H WIGBOUT G BAAS P VANTVEER L VANZANDWIJK N
Citation: Fj. Vanschooten et al., P-32 POSTLABELING OF AROMATIC DNA-ADDUCTS IN WHITE BLOOD-CELLS AND ALVEOLAR MACROPHAGES OF SMOKERS - SATURATION AT HIGH EXPOSURES, Mutation research, 378(1-2), 1997, pp. 65-75
PHOTODYNAMIC THERAPY AS ADJUVANT THERAPY IN SURGICALLY TREATED PLEURAL MALIGNANCIES
Authors: BAAS P MURRER L ZOETMULDER FAN STEWART FA RIS HB VANZANDWIJK N PETERSE JL RUTGERS EJT
Citation: P. Baas et al., PHOTODYNAMIC THERAPY AS ADJUVANT THERAPY IN SURGICALLY TREATED PLEURAL MALIGNANCIES, British Journal of Cancer, 76(6), 1997, pp. 819-826
PHOTODYNAMIC THERAPY - A PROMISING NEW MODALITY FOR THE TREATMENT OF CANCER
Authors: SCHUITMAKER JJ BASS P VANLEENGOED HLLM VANDERMEULEN FW STAR WM VANZANDWIJK N
Citation: Jj. Schuitmaker et al., PHOTODYNAMIC THERAPY - A PROMISING NEW MODALITY FOR THE TREATMENT OF CANCER, Journal of photochemistry and photobiology.B, Biology, 34(1), 1996, pp. 3-12
THE TOXICITY OF RADIOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN HIGH-RISK BREAST-CANCER - A PRELIMINARY-ANALYSIS
Authors: VANDERWALL E SCHAAKEKONING CCE VANZANDWIJK N BAARS JW SCHORNAGEL JH RICHEL DJ RUTGERS EJT BORGER JH BEIJNEN JH RODENHUIS S
Citation: E. Vanderwall et al., THE TOXICITY OF RADIOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN HIGH-RISK BREAST-CANCER - A PRELIMINARY-ANALYSIS, European journal of cancer, 32A(9), 1996, pp. 1490-1497
ORAL IFOSFAMIDE MESNA VERSUS INTRAVENOUS IFOSFAMIDE/MESNA IN NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE EORTC LUNG-CANCER COOPERATIVE GROUP/
Authors: MANEGOLD C DRINGS P PAWINSKI A LENTZ MA VANGLABBEKE M VANZANDWIJK N BACHMANN P SCHNAARS Y SKACEL Z ZATLOUKAL P DOLENSKY J JACKEVICIUS A PETRUZELKA L GIACCONE G
Citation: C. Manegold et al., ORAL IFOSFAMIDE MESNA VERSUS INTRAVENOUS IFOSFAMIDE/MESNA IN NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE EORTC LUNG-CANCER COOPERATIVE GROUP/, Annals of oncology, 7(6), 1996, pp. 637-639
RECOVERY OF OVERALL AND LOCAL LUNG-FUNCTION LOSS 18 MONTHS AFTER IRRADIATION FOR MALIGNANT-LYMPHOMA
Authors: BOERSMA LJ DAMEN EMF DEBOER RW MULLER SH OLMOS RAV VANZANDWIJK N LEBESQUE JV
Citation: Lj. Boersma et al., RECOVERY OF OVERALL AND LOCAL LUNG-FUNCTION LOSS 18 MONTHS AFTER IRRADIATION FOR MALIGNANT-LYMPHOMA, Journal of clinical oncology, 14(5), 1996, pp. 1431-1441
CISPLATIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR LOCALLY ADVANCEDOR METASTATIC THYMOMA - A PHASE-II STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP
Authors: GIACCONE G ARDIZZONI A KIRKPATRICK A CLERICO M SAHMOUD T VANZANDWIJK N
Citation: G. Giaccone et al., CISPLATIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR LOCALLY ADVANCEDOR METASTATIC THYMOMA - A PHASE-II STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP, Journal of clinical oncology, 14(3), 1996, pp. 814-820
2 SCHEDULES OF TENIPOSIDE WITH OR WITHOUT CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP
Authors: SPLINTER TAW SAHMOUD T FESTEN J VANZANDWIJK N SORENSON S CLERICO M BURGHOUTS J DAUTZENBERG B KHO GS KIRKPATRICK A GIACCONE G
Citation: Taw. Splinter et al., 2 SCHEDULES OF TENIPOSIDE WITH OR WITHOUT CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP, Journal of clinical oncology, 14(1), 1996, pp. 127-134
SMOKERS AND URINARY GENOTOXINS - IMPLICATIONS FOR SELECTION OF COHORTS AND MODULATION OF END-POINTS IN CHEMOPREVENTION TRIALS
Authors: DEFLORA S CAMOIRANO A BAGNASCO M BENNICELLI C VANZANDWIJK N WIGBOUT G QIAN GS ZHU YR KENSLER TW
Citation: S. Deflora et al., SMOKERS AND URINARY GENOTOXINS - IMPLICATIONS FOR SELECTION OF COHORTS AND MODULATION OF END-POINTS IN CHEMOPREVENTION TRIALS, Journal of cellular biochemistry, 1996, pp. 92-98
RADIATION PNEUMONITIS IMAGED WITH INDIUM-111-PENTETREOTIDE
Authors: OLMOS RAV VANZANDWIJK N BOERSMA LJ HOEFNAGEL CA BAAS P BAARS JB MULLER SH LEBESQUE JV
Citation: Rav. Olmos et al., RADIATION PNEUMONITIS IMAGED WITH INDIUM-111-PENTETREOTIDE, The Journal of nuclear medicine, 37(4), 1996, pp. 584-588
RESULTS OF THE PHASE-II EORTC STUDY COMPARING PACLITAXEL CISPLATIN WITH TENIPOSIDE/CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER/
Authors: POSTMUS PE GIACCONE G DEBRUYNE C SAHMOUD T SPLINTER TAW VANZANDWIJK N
Citation: Pe. Postmus et al., RESULTS OF THE PHASE-II EORTC STUDY COMPARING PACLITAXEL CISPLATIN WITH TENIPOSIDE/CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 23(5), 1996, pp. 10-13
PACLITAXEL FOR MALIGNANT PLEURAL MESOTHELIOMA - A PHASE-II STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP
Authors: VANMEERBEECK J DEBRUYNE C VANZANDWIJK N POSTMUS PE PENNUCCI MC VANBREUKELEN F GALDERMANS D GROEN H PINSON P VANGLABBEKE M VANMARCK E GIACCONE G
Citation: J. Vanmeerbeeck et al., PACLITAXEL FOR MALIGNANT PLEURAL MESOTHELIOMA - A PHASE-II STUDY OF THE EORTC LUNG-CANCER COOPERATIVE GROUP, British Journal of Cancer, 74(6), 1996, pp. 961-963
ENHANCEMENT OF PHOTODYNAMIC THERAPY BY MITOMYCIN-C - A PRECLINICAL AND CLINICAL-STUDY
Authors: BAAS P VANGEEL IPJ OPPELAAR H MEYER M BEYNEN JH VANZANDWIJK N STEWART FA
Citation: P. Baas et al., ENHANCEMENT OF PHOTODYNAMIC THERAPY BY MITOMYCIN-C - A PRECLINICAL AND CLINICAL-STUDY, British Journal of Cancer, 73(8), 1996, pp. 945-951
Risultati: 1-25 | 26-50 | 51-63